In chronic myelogenous leukemia (CML), the breakpoint cluster region-Abelson (BCR-ABL) fusion protein is a well-characterized causal agent, which is a result of chromosomal translocation [42]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.